Celldex Therapeutics, Inc.

BARCLAYS PLC CLDX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

240,594

Value ($000)

6,535

Weight

0.0%

2020 Q2 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	6,535	0.0%	240,594	12/31/2025
2025 Q3	3/31/2026	6,334	0.0%	244,825	9/30/2025
2025 Q2	2/27/2026	5,346	0.0%	262,725	6/30/2025
2025 Q1	3/17/2026	2,116	0.0%	116,566	3/31/2025
2024 Q4	3/19/2026	3,611	0.0%	142,914	12/31/2024
2024 Q3	3/31/2026	4,432	0.0%	130,381	9/30/2024
2024 Q2	3/23/2026	2,005	0.0%	54,174	6/30/2024
2024 Q1	3/24/2026	2,800	0.0%	66,714	3/31/2024
2023 Q4	3/25/2026	5,786	0.0%	145,894	12/31/2023
2023 Q3	3/26/2026	3,948	0.0%	143,463	9/30/2023
2023 Q2	3/30/2026	5,841	0.0%	172,134	6/30/2023
2023 Q1	3/30/2026	3,923	0.0%	109,024	3/31/2023
2022 Q4	3/30/2026	5,191	0.0%	116,471	12/31/2022
2022 Q3	11/3/2022	4,064	0.0%	144,587	9/30/2022
2022 Q2	8/12/2022	2,618	0.0%	97,087	6/30/2022
2022 Q1	5/16/2022	7,041	0.0%	206,700	3/31/2022
2021 Q4	2/14/2022	5,408	0.0%	139,952	12/31/2021
2021 Q3	11/9/2021	2,147	0.0%	39,768	9/30/2021
2021 Q2	8/13/2021	730	0.0%	21,825	6/30/2021
2021 Q1	5/13/2021	1,140	0.0%	55,299	3/31/2021
2020 Q4	2/11/2021	9	0.0%	500	12/31/2020
2020 Q3	11/12/2020	13	0.0%	866	9/30/2020
2020 Q2	8/12/2020	0	0.0%	2	6/30/2020